PDF herunterladen
Synthesis 2011(15): 2357-2368  
DOI: 10.1055/s-0030-1260100
FEATUREARTICLE
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of N-Alkyl-N-hydroxyguanidines: A Comparative Study Using Different Protecting Group Strategies

Oliver Ries, Anne Ochmann, Christian Ducho*
Georg-August-University Göttingen, Department of Chemistry, Institute of Organic and Biomolecular Chemistry, Tammannstr. 2, 37077 Göttingen, Germany
Fax: +49(551)399660; e-Mail: cducho@gwdg.de;
Weitere Informationen

Publikationsverlauf

Received 20 May 2011
Publikationsdatum:
08. Juli 2011 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik

Abstract

Representing a prime example of the interesting structures found in natural products, the N-alkyl-N-hydroxyguanidine moiety has so far only found limited attention in synthetic organic chemistry. Our studies on Streptomyces-produced muraymycin nucleoside antibiotics have led to a systematic investigation of the synthetic access to the N-hydroxyguanidine-functionalized lipid structure of biologically potent A-series muraymycins. A protecting-group-free approach has been proven to be superior to a strategy employing highly reactive urethane-protected guanidinylation reagents, particularly due to the unexpected instability of fully protected N-alkyl-N-hydroxyguanidines. The protecting-group-free method has been used for the synthesis of other N-alkyl-N-hydroxy­guanidine derivatives, namely the antibiotic N 5-hydroxy-l-arginine. These synthetic results will enable the elucidation of the properties and biological significance of the N-alkyl-N-hydroxyguanidine functionality.

Key words

natural products - antibiotics - guanidines - guanidinylation - protecting groups

    References

  • 1a Kinnel AB. Gehrken HP. Scheuer PJ. J. Am. Chem. Soc.  1993,  115:  3376 
    Google Scholar
  • 1b Seiple IB. Su S. Young IS. Lewis CA. Yamaguchi J. Baran PS. Angew. Chem. Int. Ed.  2010,  49:  1095 ; Angew. Chem. 2010, 122, 1113
    Google Scholar
  • 2a Wani MC. Taylor HL. Wall ME. Coggon P. McPhail AT. J. Am. Chem. Soc.  1971,  93:  2325 
    Google Scholar
  • 2b Wall ME. Wani MC. Cancer Res.  1995,  55:  753 
    Google Scholar
  • 3 Schmid G. Hofheinz W. J. Am. Chem. Soc.  1983,  105:  624 
    CrossrefGoogle Scholar
  • 4 Stuehr DJ. Kwon NS. Nathan CF. Griffith OW. Feldman PL. Wiseman J. J. Biol. Chem.  1991,  266:  6259 
    Google Scholar
  • 5a Dobashi K. Matsuda N. Hamada M. Naganawa H. Takita T. Takeuchi T. J. Antibiot.  1988,  41:  1525 
    Google Scholar
  • 5b Dobashi K. Naganawa H. Takahashi Y. Takita T. Takeuchi T. J. Antibiot.  1988,  41:  1533 
    Google Scholar
  • 6a Maehr H. Blount JF. Pruess DL. Yarmchuk L. Kellett M. J. Antibiot.  1973,  26:  284 
    Google Scholar
  • 6b Perlman D. Vlietinck AJ. Matthews HW. Lo FF. J. Antibiot.  1974,  27:  826 
    Google Scholar
  • 7 Seto H. Koyama M. Ogino H. Tsuruoka T. Tetrahedron Lett.  1983,  24:  1805 
    CrossrefGoogle Scholar
  • 8 Nemoto A. Hoshino Y. Yazawa K. Ando A. Mikami Y. J. Antibiot.  2002,  55:  593 
    CrossrefGoogle Scholar
  • 9a Kimura K.-I. Bugg TDH. Nat. Prod. Rep.  2003,  20:  252 
    Google Scholar
  • 9b Winn M. Goss RJM. Kimura K.-I. Bugg TDH. Nat. Prod. Rep.  2010,  27:  279 
    Google Scholar
  • 10a Taubes G. Science  2008,  321:  356 
    Google Scholar
  • 10b Walsh C. Nat. Rev. Microbiol.  2003,  1:  65 
    Google Scholar
  • 10c Dini C. Curr. Top. Med. Chem.  2005,  5:  1221 
    Google Scholar
  • 10d Bugg TDH. Lloyd AJ. Roper DI. Infect. Disorders Drug Targets  2006,  6:  85 
    Google Scholar
  • 11 McDonald LA. Barbieri LR. Carter GT. Lenoy E. Lotvin J. Petersen PJ. Siegel MM. Singh G. Williamson RT. J. Am. Chem. Soc.  2002,  124:  10260 
    CrossrefGoogle Scholar
  • 12 Jones JH. J. Peptide Sci.  2002,  8:  285 
    CrossrefGoogle Scholar
  • 13 Heesing A. Peppmöller R. Z. Naturforsch., B: Chem. Sci.  1967,  22:  820 
    Google Scholar
  • 14a Widmer J. Keller-Schierlein W. Helv. Chim. Acta  1974,  57:  657 
    Google Scholar
  • 14b Maehr H. Leach M. J. Org. Chem.  1974,  39:  1166 
    Google Scholar
  • 15 Dutta SP. Bernacki RJ. Bloch A. Chheda GB. Nucleosides Nucleotides  1990,  9:  151 
    CrossrefGoogle Scholar
  • 16a Feichtinger K. Sings HL. Baker TJ. Matthews K. Goodman M. J. Org. Chem.  1998,  63:  8432 
    Google Scholar
  • 16b Zapf CW. Goodman M. J. Org. Chem.  2003,  68:  10092 
    Google Scholar
  • 17 Mithran S. Subbaraman AS. Molecules  1999,  4:  159 
    CrossrefGoogle Scholar
  • 18 Adlof RO. Miller WR. Emken EA. J. Labelled Compd. Radiopharm.  1978,  15:  625 
    CrossrefGoogle Scholar
  • 19 Mezl VA. Knox WE. Anal. Biochem.  1976,  74:  430 
    CrossrefGoogle Scholar
  • 20a Burkhart F. Hoffmann M. Kessler H. Angew. Chem. Int. Ed.  1997,  36:  1191 ; Angew. Chem. 1997, 109, 1240
    Google Scholar
  • 20b Padron JM. Kokotos G. Martin T. Markidis T. Gibbons WA. Martin VS. Tetrahedron: Asymmetry  1998,  9:  3381 
    Google Scholar
  • 20c Sutherland A. Caplan JF. Vederas JC. Chem. Commun.  1999,  555 
    Google Scholar
  • 20d Luesch H. Hoffmann D. Hevel JM. Becker JE. Golakoti T. Moore RE.
    J. Org. Chem.  2003,  68:  83 
    Google Scholar
  • 20e Sorensen JL. Sleeman MC. Schofield CJ. Chem. Commun.  2005,  1155 
    Google Scholar
  • 21 Farrant RD. Walker V. Mills GA. Mellor JM. Langley GJ. J. Biol. Chem.  2001,  276:  15107 
    CrossrefGoogle Scholar
  • 22 Ducho C. Hamed RB. Batchelar ET. Sorensen JL. Odell B. Schofield CJ. Org. Biomol. Chem.  2009,  7:  2770 
    CrossrefGoogle Scholar
  • 23 Batchelar ET. Hamed RB. Ducho C. Claridge TDW. Edelmann MJ. Kessler B. Schofield CJ. Angew. Chem. Int. Ed.  2008,  47:  9322 ; Angew. Chem. 2008, 120, 9462
    CrossrefGoogle Scholar
  • 24 Wang W. Xiong C. Yang J. Hruby VJ. Synthesis  2002,  94 
    Google Scholar
  • 25 Gebhardt P. Crumbliss AL. Miller MJ. Möllmann U. Biometals  2008,  21:  41 
    CrossrefGoogle Scholar